(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
Star0
Identification
- Generic Name
- (2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
- DrugBank Accession Number
- DB07500
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 338.397
Monoisotopic: 338.151809192 - Chemical Formula
- C21H22O4
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UGroup IIE secretory phospholipase A2 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as 3-prenylated chalcones. These are chalcones featuring a C5-isoprenoid unit at the 3-position.
- Kingdom
- Organic compounds
- Super Class
- Phenylpropanoids and polyketides
- Class
- Linear 1,3-diarylpropanoids
- Sub Class
- Chalcones and dihydrochalcones
- Direct Parent
- 3-prenylated chalcones
- Alternative Parents
- 2'-Hydroxychalcones / Cinnamylphenols / Hydroxycinnamic acids and derivatives / Methoxyphenols / Anisoles / Aryl ketones / Benzoyl derivatives / Styrenes / Phenoxy compounds / Methoxybenzenes show 7 more
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / 2'-hydroxychalcone / 3-prenylated chalcone / Acryloyl-group / Alkyl aryl ether / Alpha,beta-unsaturated ketone / Anisole / Aromatic homomonocyclic compound / Aryl ketone / Benzenoid show 18 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Chalcones and dihydrochalcones (LMPK12120046)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- ZUGCRBMNFSAUOC-YRNVUSSQSA-N
- InChI
- InChI=1S/C21H22O4/c1-14(2)4-8-16-12-18(20(24)13-21(16)25-3)19(23)11-7-15-5-9-17(22)10-6-15/h4-7,9-13,22,24H,8H2,1-3H3/b11-7+
- IUPAC Name
- (2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
- SMILES
- COC1=CC(O)=C(C=C1CC=C(C)C)C(=O)\C=C\C1=CC=C(O)C=C1
References
- General References
- Not Available
- External Links
- PDB Entries
- 2zbh
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00322 mg/mL ALOGPS logP 4.49 ALOGPS logP 5.5 Chemaxon logS -5 ALOGPS pKa (Strongest Acidic) 7.07 Chemaxon pKa (Strongest Basic) -4.9 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 66.76 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 101.54 m3·mol-1 Chemaxon Polarizability 37.26 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9781 Blood Brain Barrier - 0.6568 Caco-2 permeable + 0.8105 P-glycoprotein substrate Substrate 0.6936 P-glycoprotein inhibitor I Inhibitor 0.5522 P-glycoprotein inhibitor II Inhibitor 0.7256 Renal organic cation transporter Non-inhibitor 0.8045 CYP450 2C9 substrate Non-substrate 0.7783 CYP450 2D6 substrate Non-substrate 0.8473 CYP450 3A4 substrate Substrate 0.622 CYP450 1A2 substrate Inhibitor 0.8444 CYP450 2C9 inhibitor Inhibitor 0.7744 CYP450 2D6 inhibitor Non-inhibitor 0.6658 CYP450 2C19 inhibitor Inhibitor 0.9503 CYP450 3A4 inhibitor Non-inhibitor 0.7365 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.9044 Ames test Non AMES toxic 0.9159 Carcinogenicity Non-carcinogens 0.8354 Biodegradation Not ready biodegradable 0.8908 Rat acute toxicity 2.2755 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9251 hERG inhibition (predictor II) Non-inhibitor 0.8271
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-0259000000-2771eed2a5bf78ed7b03 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-014r-0095000000-3e0714fcb2534d7d8a73 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00kr-0629000000-a254aa9658a60575425f Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-000j-1948000000-f15c43b1264e36587c2d Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-014i-0972000000-b4d257a828ad06df7561 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0wml-2911000000-e9a8d93bf610b8647fce Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 211.7762382 predictedDarkChem Lite v0.1.0 [M-H]- 188.46379 predictedDeepCCS 1.0 (2019) [M+H]+ 211.9472382 predictedDarkChem Lite v0.1.0 [M+H]+ 190.86107 predictedDeepCCS 1.0 (2019) [M+Na]+ 211.6492382 predictedDarkChem Lite v0.1.0 [M+Na]+ 198.05133 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsGroup IIE secretory phospholipase A2
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Phospholipase a2 activity
- Specific Function
- PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Has a preference for arachidonic-containing phospholipids.
- Gene Name
- PLA2G2E
- Uniprot ID
- Q9NZK7
- Uniprot Name
- Group IIE secretory phospholipase A2
- Molecular Weight
- 15988.525 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:23 / Updated at June 12, 2020 16:52